NanoGroup S.A.
NNG | WAR
Overview
Corporate Details
- ISIN(s):
- PLNNGRP00011 (+3 more)
- LEI:
- 259400HXWEAZUWRLY648
- Country:
- Poland
- Address:
- Warszawa Rakowiecka 36, 02-532 Warszawa
- Website:
- https://en.nanogroup.eu/
- Sector:
- Professional, scientific and technical activities
- Industry:
- Research and experimental development on natural sciences and engineering
Description
Mission of NanoGroup is to build a cluster of medical and biotechnological companies active in the field of diagnostics, therapy and rehabilitation of oncological patients. Currently, the group is managing five technologically advanced nanoengineering projects organized under three specialized startups. NanoGroup plans to sell licenses to its early-stage solutions (pre-clinical and clinical phase 1st) to international biotech companies and pharmaceutical companies.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-08-12 22:27 |
Director's Dealing
Powiadomienie
|
Polish | 4.3 KB | |
| 2025-08-12 22:27 |
Director's Dealing
Powiadomienie o transakcji, o którym mowa w art. 19 ust. 1 rozporządzenia MAR -…
|
Polish | 472 bytes | |
| 2025-08-12 22:20 |
Director's Dealing
Powiadomienie
|
Polish | 4.3 KB | |
| 2025-08-12 22:20 |
Director's Dealing
Powiadomienie o transakcji, o którym mowa w art. 19 ust. 1 rozporządzenia MAR -…
|
Polish | 466 bytes | |
| 2025-08-12 22:12 |
Director's Dealing
Powiadomienie
|
Polish | 4.3 KB | |
| 2025-08-12 22:12 |
Director's Dealing
Powiadomienie o transakcji, o którym mowa w art. 19 ust. 1 rozporządzenia MAR -…
|
Polish | 461 bytes | |
| 2025-08-12 22:04 |
Director's Dealing
Powiadomienie
|
Polish | 4.3 KB | |
| 2025-08-12 22:04 |
Director's Dealing
Powiadomienie o transakcji, o którym mowa w art. 19 ust. 1 rozporządzenia MAR -…
|
Polish | 482 bytes | |
| 2025-08-12 16:19 |
Share Issue/Capital Change
Zakończenie subskrypcji akcji zwykłych na okaziciela serii K - Content (PL)
|
Polish | 3.7 KB | |
| 2025-08-11 16:14 |
Regulatory News Service
Oświadczenie KDPW
|
Polish | 175.4 KB | |
| 2025-08-11 16:14 |
Regulatory News Service
Asymilacja akcji oznaczonych kodem "PLNNGRP00086" z notowanymi akcjami oznaczon…
|
Polish | 669 bytes | |
| 2025-08-06 18:01 |
Regulatory News Service
Dopuszczenie i wprowadzenie do obrotu giełdowego Akcji Serii L1, M1, M2, M3, M4…
|
Polish | 2.0 KB | |
| 2025-08-04 14:39 |
Regulatory News Service
Zawarcie przez spółkę zależną od NanoGroup S.A. umowy o dofinansowanie projektu…
|
Polish | 6.2 KB | |
| 2025-07-22 18:59 |
Transaction in Own Shares
Zawarcie transakcji sprzedaży akcji własnych spółki - Content (PL)
|
Polish | 1.2 KB | |
| 2025-07-10 13:26 |
Share Issue/Capital Change
Uchwała
|
Polish | 67.2 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
EUROESPES | Spain | EEP | |
|
European Institute of Science AB | Sweden | EURI B | |
|
European Medical Solutions | Belgium | ALEMS | |
|
Evogene Ltd. | Israel | EVGN | |
|
Evolva Holding SA | Switzerland | EVE | |
|
EXACT Therapeutics AS | Norway | EXTX | |
|
Exosens | France | EXENS | |
|
ExpreS2ion Biotech Holding AB | Sweden | EXPRS2 | |
|
Fermentalg | France | ALGAE | |
|
Formycon AG | Germany | FYB |